Neuroendoscopy has emerged as a viable alternative to other minimal invasive surgical procedures such as the Micro-neurosurgeries. Strong prevalence of neurological disorders, rising demand for minimal invasive surgical procedures, and technological advancements are the key forces driving the growth of Neuroendoscopy devices market worldwide. The Neuroendoscopy devices are primarily used in minimal invasive surgeries for the treatment of obstructive hydrocephalus, intraventricular & paraventricular tumors & cysts, clival chordomas, pituitary adenomas, meningiomas, and craniopharyngiomas. Additionally, the demand for skull base trans nasal transsphenoidal endoscopy is increasing for treating the large skull base lesions, which is expected to contribute towards the growth of Neuroendoscopy devices market in coming years. With government initiatives and favorable regulatory framework is anticipated to drive the Neuroendoscopy devices market during the forecast period.
North America contributed a dominating share to the global Neuroendoscopy devices market in 2019 and is anticipated to be a dominating geography during the forecast period due to prevalence of neurological diseases, adoption of advanced medical devices for treatment of intricate neurology conditions, and high penetration of minimal invasive surgical procedures. Additionally, increasing investment in product innovation, presence of leading manufacturers, and favorable regulatory framework are anticipated to contribute to the growth of North America Neuroendoscopy devices market in coming years. The Asia Pacific Neuroendoscopy devices market is expected to witness prominent growth during the forecast period owing to increasing awareness about minimal invasive surgeries, expansion of healthcare equipment manufacturing industry, and increasing incidences of neurological disorders across the region.
The report titled “Neuroendoscopy Devices Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032” wherein 2021 is historic period, 2022 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global Neuroendoscopy devices market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market. For instance, B. Braun Melsungen AG reported revenues of USD 8082.2 million in 2019 and the product segment analysis of the company indicates that B.Braun Hospital Care business segment of the company dominated revenue in 2019.
The global Neuroendoscopy devices market is segmented based on device type, application, end user, and geography. Based on device type, the global Neuroendoscopy devices market is segmented into rigid Neuroendoscopy devices, and flexible Neuroendoscopy devices. Based on application, the global Neuroendoscopy devices market is segmented into intraventricular, transcranial, and transnasal. Based on end user, the global Neuroendoscopy devices market is segmented into hospitals, research centers, and others. Based on geography, the global Neuroendoscopy Devices market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America.
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment, and would identify the segment of the company focusing on Neuroendoscopy devices. Further, market share of prominent companies in the global Neuroendoscopy devices market would also be estimated. For instance, B. Braun Melsungen AG operates through four business segments namely B.Braun Hospital Care, B.Braun Aesculap, B.Braun Out Patient Market, and B.Braun Avitum. The Neuroendoscopy devices are delivered under B.Braun Aesculap business segment of the company with revenue contribution of US$ 3,632.5 million in 2019.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focus of all the Neuroendoscopy devices manufacturers. The global Neuroendoscopy devices market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution. Product portfolio would focus on all the products under the Neuroendoscopy devices business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global Neuroendoscopy devices market.
Major players active in the global Neuroendoscopy devices market include Ackermann Instrumente GmbH, adeor Medical AG, B. Braun Melsungen AG, Carl Zeiss Meditec AG, Clarus Medical LLC, Hawk, KARL STORZ SE & Co. KG, Medtronic plc, Olympus Corporation, SCHINDLER ENDOSKOPIE TECHNOLOGIE GmbH, Stryker, and Tonglu Wanhe Medical.
Market Segmentation
By Device Type
- Rigid Neuroendoscopy devices
- Flexible Neuroendoscopy devices
By Application
- Intraventricular
- Transcranial
- Transnasal
By End user
- Hospitals
- Research centers
- Others
By Geography
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- South America
